CoFe2O4 magnetic nanoparticles as a highly active heterogeneous catalyst of oxone for the degradation of diclofenac in water

•CoFe2O4 MNPs tested as heterogeneous catalyst for the activation of oxone.•The catalytic performance was typically affected by several key operating parameters.•The catalyst exhibited good stability and easily recovered with excellent reusability.•Degradation pathway was proposed according to the r...

Full description

Saved in:
Bibliographic Details
Published inJournal of hazardous materials Vol. 262; pp. 836 - 844
Main Authors Deng, Jing, Shao, Yisheng, Gao, Naiyun, Tan, Chaoqun, Zhou, Shiqing, Hu, Xuhao
Format Journal Article
LanguageEnglish
Published Kidlington Elsevier B.V 15.11.2013
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:•CoFe2O4 MNPs tested as heterogeneous catalyst for the activation of oxone.•The catalytic performance was typically affected by several key operating parameters.•The catalyst exhibited good stability and easily recovered with excellent reusability.•Degradation pathway was proposed according to the results of LC-MS/MS analysis. A magnetic nanoscaled catalyst cobalt ferrite (CoFe2O4) was successfully prepared and used for the activation of oxone to generate sulfate radicals for the degradation of diclofenac. The catalyst was characterized by transmission electron microscopy, X-ray diffractometry, Fourier transform infrared spectroscopy and vibrating sample magnetometer. The effects of calcination temperature, initial pH, catalyst and oxone dosage on the degradation efficiency were investigated. Results demonstrated that CoFe2O4-300 exhibited the best catalytic performance and almost complete removal of diclofenac was obtained in 15min. The degradation efficiency increased with initial pH decreasing in the pH range of 5–9. The increase of catalyst and oxone dosage both had the positive effect on the degradation of diclofenac. Moreover, CoFe2O4 could retain high degradation efficiency even after being reused for five cycles. Finally, the major diclofenac degradation intermediates were identified and the primary degradation pathways were proposed.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0304-3894
1873-3336
DOI:10.1016/j.jhazmat.2013.09.049